Peer-reviewedCC BYMedical sciences (Basel, Switzerland)
Transcriptomic Profiling Reveals METTL26 as a Potential Biomarker in Head and Neck Squamous Cell Carcinoma with Independent Validation in Oral Squamous Cell Carcinoma
- 1Department for the Promotion of Human Science and Quality of Life, San Raffaele Roma University, Via di Val Cannuta, 247, 00166 Rome, Italy; (R.R.); (S.D.Z.); (G.T.)
- 2Department of General Surgery and Surgical-Medical Specialties, School of Dentistry, , 95123 Catania, Italy; (A.P.); (G.I.)
Related
- Transcriptomic profiling of tropomyosin isoforms in bladder cancer: multi-platform sequencing and experimental validation
- Transcriptomic Profiling of Mouse Mammary Tumors Enables Prognostic and Predictive Biomarker Discovery for Human Breast Cancer
- Transcriptomic Profiling and Demographic Analysis of Appalachian Patients with Pancreatic Ductal Adenocarcinoma using the Purity Independent Subtyping of Tumors (PurIST) Classifier
- Multi-omics profiling highlights RPLP0 as a potential biomarker for prognosis and response to immunotherapy in clear cell renal cell carcinoma
- Integrated Transcriptomic Analysis Identifies ENO3 as a Candidate Lactate Metabolism‐Associated Biomarker in Colorectal Cancer Metastasis
BibTeX
@article{rotondo2026transcriptomic,
title = {{Transcriptomic Profiling Reveals METTL26 as a Potential Biomarker in Head and Neck Squamous Cell Carcinoma with Independent Validation in Oral Squamous Cell Carcinoma}},
author = {Rossella Rotondo and Alessandro Polizzi and Sabrina Donati Zeppa and Gaetano Isola and Roberto Campagna and Giovanni Tossetta},
journal = {Medical sciences (Basel, Switzerland)},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13707005},
note = {CC BY},
}
RIS
TY - JOUR
TI - Transcriptomic Profiling Reveals METTL26 as a Potential Biomarker in Head and Neck Squamous Cell Carcinoma with Independent Validation in Oral Squamous Cell Carcinoma
AU - Rossella Rotondo
AU - Alessandro Polizzi
AU - Sabrina Donati Zeppa
AU - Gaetano Isola
AU - Roberto Campagna
AU - Giovanni Tossetta
PY - 2026
DA - 2026/10/01
JO - Medical sciences (Basel, Switzerland)
UR - https://europepmc.org/article/PMC/PMC13707005
SN - 2076-3271
ER -